Antimicrobial activity and spectrum of cefovecin, a new extended- spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America.
about
Pharmacokinetics of cefovecin in cynomolgus macaques (Macaca fascicularis), olive baboons (Papio anubis), and rhesus macaques (Macaca mulatta)Bacterial species isolated from cats with lower urinary tract infection and their susceptibilities to cefovecin.Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs.Effect of proximal versus distal 50% enterectomy on nutritional parameters in rats preconditioned with a high-fat diet or regular chow.Staphylococcus pseudintermedius and Staphylococcus schleiferi Subspecies coagulans from Canine Pyoderma Cases in Grenada, West Indies, and Their Susceptibility to Beta-Lactam Drugs.Update in feline therapeutics: clinical use of 10 emerging therapies.Pharmacokinetics and local tolerance of cefovecin sodium after intra-articular administration in horses.Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.Pharmacokinetics of Cefovecin in squirrel monkey (Saimiri sciureus), rhesus macaques (Macaca mulatta), and cynomolgus macaques (Macaca fascicularis)Pharmacokinetics of intravenous and subcutaneous cefovecin in alpacas.Efficacy and safety of cefovecin (Convenia) for the treatment of urinary tract infections in dogs.Cephalexin susceptibility breakpoint for veterinary isolates: Clinical Laboratory Standards Institute revision.Efficacy and safety of cefovecin for the treatment of urinary tract infections in cats.Pharmacokinetics of Single-bolus Subcutaneous Cefovecin in C57BL/6 Mice.
P2860
Q35010834-E0DBD5ED-2AF1-42B3-83C3-DA52CBA49673Q35149967-FFF540F7-502B-4F06-890C-86F70FD4C667Q35708998-F0E272C6-169E-48B9-A7CB-53026EC98749Q36323762-087AC0C5-97CA-467F-9A62-4C518F80C2F2Q37579490-4D7992BA-8FD1-4C53-A6E4-E391224F4364Q38363411-F1444EA2-6CD0-48D8-9313-1B4741D4F777Q38853106-D6852985-915E-4C20-9D08-44A2BEAD6785Q40410184-C117549B-B93E-4DE9-B0BF-620581DD1D2AQ41429376-9D9D3500-6136-4B81-8438-495833516BE7Q41656657-EC94A4B2-FD19-4D88-92FF-6ACDA6F2A976Q42169170-1EFA8970-FF62-481C-A5D5-7A387F909BA7Q44877139-D74354D6-373E-4083-B90C-C13593E93712Q46636635-06AAB366-4A99-4EB6-8FE1-52291E5FF31DQ50114852-29DDB3B0-1BF6-44DC-BD29-7E2363FEB12D
P2860
Antimicrobial activity and spectrum of cefovecin, a new extended- spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antimicrobial activity and spe ...... s in Europe and North America.
@ast
Antimicrobial activity and spe ...... s in Europe and North America.
@en
Antimicrobial activity and spe ...... s in Europe and North America.
@nl
type
label
Antimicrobial activity and spe ...... s in Europe and North America.
@ast
Antimicrobial activity and spe ...... s in Europe and North America.
@en
Antimicrobial activity and spe ...... s in Europe and North America.
@nl
prefLabel
Antimicrobial activity and spe ...... s in Europe and North America.
@ast
Antimicrobial activity and spe ...... s in Europe and North America.
@en
Antimicrobial activity and spe ...... s in Europe and North America.
@nl
P2093
P2860
P356
P1476
Antimicrobial activity and spe ...... s in Europe and North America.
@en
P2093
C A Passmore
C J Lindeman
D J Weigel
J Sherington
M R Stegemann
T L Skogerboe
P2860
P304
P356
10.1128/AAC.00077-06
P407
P577
2006-07-01T00:00:00Z